2025-07-08 - Analysis Report
Okay, here's an analysis report for Intuitive Surgical Inc (ISRG), incorporating all the data you provided.

**Report: Intuitive Surgical Inc (ISRG) Analysis**

**1. Performance Overview vs. S&P 500 (VOO)**

*   **Ticker:** ISRG
*   **Company:** Intuitive Surgical Inc
*   **Description:** Intuitive Surgical is a global leader in robotic-assisted surgery, developing and manufacturing the da Vinci surgical system.

**Key Metrics:**

*   **ISRG Cumulative Return:** 132.26%
*   **VOO (S&P 500) Cumulative Return:** 95.42%
*   **Absolute Difference (ISRG - VOO):** 37.7%
*   **Range of Historical Differences (Max: 127.7, Min: -6.8)**
*   **Relative Difference Percentile:** 33.1

**Analysis:**

ISRG has significantly outperformed the S&P 500 (VOO) over the period considered, with a cumulative return difference of 37.7%.  The 'Relative Difference Percentile' of 33.1 suggests that while ISRG has historically outperformed, its current outperformance is in the lower portion of its historical range.  This means that while the stock is doing well, it isn't at the peak of its historical outperformance relative to the S&P 500.

**Alpha and Beta Analysis (Rolling 3-Year Periods):**

| Year       | CAGR   | MDD    | Alpha | Beta | Cap(B) |
|------------|--------|--------|-------|------|--------|
| 2015-2017  | 68.0%  | 56.5%  | 39.0% | 0.0  | 42.7   |
| 2016-2018  | 77.0%  | 63.4%  | 59.0% | 0.0  | 56.0   |
| 2017-2019  | 81.0%  | 63.4%  | 52.0% | 0.3  | 69.1   |
| 2018-2020  | 47.0%  | 63.4%  | 28.0% | 0.2  | 95.7   |
| 2019-2021  | 91.0%  | 63.0%  | 43.0% | 0.2  | 126.1  |
| 2020-2022  | -3.0%  | 69.9%  | -6.0% | 0.2  | 93.1   |
| 2021-2023  | -5.0%  | 72.9%  | -23.0% | 0.9  | 118.4  |
| 2022-2024  | 26.0%  | 72.9%  | 0.0%  | 0.9  | 183.1  |
| 2023-2025  | 53.0%  | 72.9%  | 6.0%  | 0.6  | 191.0  |

**Analysis:**

*   **CAGR:** Shows strong growth historically, although recent periods (2020-2023) experienced negative CAGR. More recent results(2023-2025) shows positive results.
*   **MDD (Maximum Drawdown):** High MDD values indicate significant volatility and potential for large price drops. MDD has been consistently high, exceeding 50% in all the time windows.
*   **Alpha:** High alpha values in earlier periods indicate significant outperformance relative to the market.  The negative alpha in 2020-2023 period indicates underperformance.
*   **Beta:** Beta values are generally low, suggesting ISRG's price movements are less correlated with the overall market. In recent years, beta increased to 0.9
*   **Cap(B):** Consistently growing Market Cap

**2. Recent Price Action**

*   **Current Price:** 544.47
*   **Last-market:**  Price: 532.9, Previous Close: 544.47, Change: -2.13
*   **5-Day Moving Average:** 540.97
*   **20-Day Moving Average:** 528.366
*   **60-Day Moving Average:** 527.211

**Analysis:**

The price closed at 544.47, and in the last market, the price changed to 532.9 with a difference of -2.13 from the previous close. The 5-day moving average is above the 20-day and 60-day moving averages, suggesting a short-term upward trend. The 20-day moving average is slightly above the 60-day, reinforcing this trend.

**3. Technical Indicators and Outlook**

*   **Market Risk Indicator (MRI):** 0.3301 (Low Risk)
*   **RSI:** 72.88 (Overbought)
*   **PPO:** 0.5778
*   **Hybrid Signal:** cash_0%_Buy 80% of cash (1 shares - Caution - MRI:0.33)
*   **Recent (20-day) Relative Difference Change:** 0.2 (+) (Short-term increase)
*   **Expected Return:** 83.2% (Long-term, vs. S&P 500)

**Analysis:**

*   **MRI:** Indicates low market risk.
*   **RSI:** The RSI above 70 suggests the stock is overbought and may be due for a correction.
*   **PPO:** Positive PPO indicates an upward trend.
*   **Hybrid Signal:** Suggests a buy signal but with caution due to the MRI.
*   **Recent Relative Difference Change:** The positive change in relative difference indicates short-term outperformance compared to the S&P 500.
*   **Expected Return:**  A high expected return suggests a positive long-term outlook relative to the S&P 500.
*   **Price change:** The last-market price decreasing with a change of -2.13 indicates a recent downward movement.

**4. Recent News & Significant Events**

*   **[2025-07-05]:** Major business developments, regulatory changes, or market events.
*   **[2025-07-06]:** Analyst discussions regarding performance and outlook in the context of industry trends and global economic factors.
*   **[2025-07-04]:** Notable stock volatility influenced by recent news, earnings reports, or executive actions.
*   **[2025-07-08]:** Market experts highlighting risks and opportunities, advising monitoring of news and company announcements.

**Analysis:**

Recent news suggests a dynamic environment for ISRG, with volatility, analyst discussions, and potential market-moving events.  Investors should closely monitor news and company announcements.

**5. Recent Earnings Analysis**

| 날짜       | EPS  | 매출       |
|------------|------|------------|
| 2025-04-23 | 1.95 | 2.25 B$    |
| 2024-10-18 | 1.59 | 2.04 B$    |
| 2024-07-19 | 1.48 | 2.01 B$    |
| 2024-04-19 | 1.54 | 1.89 B$    |
| 2025-04-23 | 1.54 | 1.89 B$    |

**Analysis:**

*   **EPS:** EPS(Earnings Per Share) has generally increased over the reviewed period, with a significant jump to 1.95 in the latest quarter.
*   **Revenue:** Revenue has also shown consistent growth, reaching 2.25 B$ in the most recent quarter.

This indicates strong financial performance and growth in both profitability and sales.

**6. Financial Information**

**Revenue and Profitability:**

| Quarter      | Revenue   | Profit Margin |
|--------------|-----------|---------------|
| 2025-03-31   | $2.25B    | 64.69%        |
| 2024-12-31   | $2.41B    | 68.04%        |
| 2024-09-30   | $2.04B    | 67.41%        |
| 2024-06-30   | $2.01B    | 68.30%        |
| 2024-03-31   | $1.89B    | 65.87%        |

**Capital and Profitability:**

| Quarter      | Equity    | ROE     |
|--------------|-----------|---------|
| 2025-03-31   | $17.11B   | 4.08%   |
| 2024-12-31   | $16.43B   | 4.17%   |
| 2024-09-30   | $15.58B   | 3.63%   |
| 2024-06-30   | $14.71B   | 3.58%   |
| 2024-03-31   | $13.96B   | 3.90%   |

**Analysis:**

*   **Revenue:** Revenue shows a general uptrend over the past year.
*   **Profit Margin:**  Profit margins are consistently high, indicating strong operational efficiency.
*   **Equity:** Equity has been steadily increasing.
*   **ROE (Return on Equity):** ROE is relatively stable, showing consistent profitability relative to equity.

**7. 종합 Conclusion**

Intuitive Surgical (ISRG) shows a strong financial position with growing revenue, high profit margins, and increasing equity. Recent earnings reports are positive, and the long-term expected return is promising.

However, several factors warrant caution:

*   **Overbought RSI:** Suggests a potential short-term correction.
*   **High MDD:** Indicates significant historical volatility.
*   **Recent Price Drop:** Last-market price decreasing indicates a recent downward movement.
*   **News-Driven Volatility:** Recent news highlights potential volatility and the need to monitor company announcements.

**Overall Recommendation:**

The analysis presents a mixed picture. ISRG demonstrates strong fundamentals and growth potential. The hybrid signal indicates a buy signal with caution, and the expected return(83.2%) of the company is high, so accumulating shares with a long term perspective looks good. However, investors should be aware of the potential for short-term volatility and the stock being potentially overbought. A buy-and-hold strategy, combined with careful monitoring of news and earnings, may be appropriate.
